TD SYNNEX 10.67% Fall; Glucotrack 27.09% Rise; Redwire Surges on $980M Contract

Mumbai, Sept 25: Market activity on September 24 reflected mixed investor reactions to earnings, fundraising and new business opportunities. TD SYNNEX reported stronger-than-expected third-quarter results, while Glucotrack announced a $3.1 million public offering.  

Redwire was selected for a US Space Systems Command contract valued at more than $980 million. Other notable developments included convertible note offerings, strategic investments, IPO filings and corporate transactions across technology, healthcare, defence and industrial sectors. 

TD SYNNEX Shares Fall 10.67% Despite Beating Third-Quarter Estimates 

TD SYNNEX Corporation’s (NYSE: SNX) shares came under pressure on September 24 despite the company reporting third-quarter fiscal 2026 results above analyst expectations. The stock opened at $262.12, compared with the previous close of $287.80, and fell to an intraday low of $243.03. It reached a high of $266.42 during the session. 

As of 12:58 p.m. ET, TD SYNNEX shares were trading at $257.10, down 10.67%, or $30.70, from the previous close. The session remains ongoing, so the stock’s final closing price may differ. The decline came despite adjusted earnings per share of $5.68, above the $4.64 analyst consensus, while revenue of $21.6 billion exceeded the $18.79 billion estimate. Revenue also rose 37.7% year-on-year. 

For the fourth quarter, TD SYNNEX forecast adjusted EPS of $5.65–$6.15 and revenue of $21.8–$22.6 billion, with both guidance midpoints above consensus estimates. The company also announced a quarterly dividend of $0.48 per share, up 9% year-on-year. 

H.B. Fuller Shares Fall 3.80% Despite Strong Q3 Earnings And Margin Expansion 

H.B. Fuller Company (NYSE: FUL) shares declined on September 24 despite the adhesives manufacturer reporting third-quarter fiscal 2026 earnings above analyst expectations. The stock opened at $49.29, reached an intraday high of $49.90, and fell to a low of $46.70, which also matched its current 52-week low. 

As of 1:16 p.m. ET, H.B. Fuller shares were trading at $48.41, down 3.80%, or $1.91, from the previous close of $50.32. Trading remains underway, so the final closing price may change. The share-price decline followed a mixed quarterly performance. Adjusted EPS rose 21% year-on-year to $1.52, beating the $1.47 analyst consensus. However, revenue of $938.2 million came in below the $948.25 million market expectation, keeping attention on volume pressures across several end markets. 

H.B. Fuller reported adjusted EBITDA of $187 million, up 9% year-on-year, while the adjusted EBITDA margin expanded 80 basis points to 19.9%. Adjusted gross margin also increased 120 basis points to 33.5%, supported by pricing actions and restructuring savings. The company maintained its full-year 2026 adjusted EPS guidance of $4.70–$4.85 and adjusted EBITDA guidance of $655–$670 million. 

Glucotrack Shares Rise 27.09% After Pricing $3.1 Million Public Offering 

Glucotrack Inc. (NASDAQ: GCTK) shares surged on September 24 after the company announced the pricing of a public offering expected to generate approximately $3.1 million in gross proceeds. The stock opened at $2.43, reached an intraday high of $3.25 and touched a low of $2.38. 

As of 3:21 p.m. ET, GCTK shares were trading at $2.58, up 27.09%, or $0.55, from the previous close of $2.03. The US market remains open, so the final closing price may change. 

The offering includes 169,388 shares of common stock priced at $2.04 per share and pre-funded warrants to purchase up to 1,350,220 shares at $2.039 per warrant. The transaction was priced at market under Nasdaq rules and is expected to close on or around September 25, subject to customary conditions. 

Dawson James Securities is acting as the sole placement agent. The offering is being conducted under Glucotrack’s existing Form S-3 registration statement. 

Glucotrack operates Lōkahi Therapeutics and, through Glucotrack Technologies, develops technologies for people with diabetes, including a long-term implantable continuous blood glucose monitoring system. 

Also Read: What Is the New York Stock Exchange (NYSE)?

Voyager Technologies Shares Fall 0.38% As Company Prices $350 Million Convertible Notes 

Voyager Technologies Inc. (NYSE: VOYG) shares edged lower on September 24 after the defence and space technology company announced the pricing of $350 million of 0% convertible senior notes due 2032. The stock opened at $31.35, reached an intraday high of $31.89, and fell to a low of $30.60. 

As of 1:33 p.m. ET, Voyager shares were trading at $31.28, down 0.38%, or $0.12, from the previous close of $31.40. The US market remains open, so the stock’s final closing price may change. 

The notes will mature on October 15, 2032, with an initial conversion price of approximately $40.82 per share, representing a 30% premium to the September 23 closing price. Voyager has also granted initial purchasers an option to acquire an additional $52.5 million of notes. 

The company expects net proceeds of approximately $340.4 million, rising to $391.6 million if the additional notes are fully purchased. About $45.7 million will fund capped call transactions, with the remaining proceeds intended for general corporate purposes. The capped calls have an initial cap price of $78.50 per share and are designed to reduce potential dilution from future note conversions. 

Delek US Holdings Shares Fall 5.17% After $400 Million Convertible Notes Offering 

Delek US Holdings Inc. (NYSE: DK) shares fell on September 24 after the company announced plans to offer $400 million of convertible senior notes due 2031 through a private offering. The stock opened at $68.45, reached an intraday high of $69.31, and declined to a low of $66.82. 

As of 1:43 p.m. ET, Delek US shares were trading at $68.48, down 5.17%, or $3.73, from the previous close of $72.21. The US market remains open, so the stock’s final closing price could change. 

The proposed notes will mature on November 1, 2031, with the interest rate, initial conversion rate and other terms to be determined when the offering is priced. Delek also expects to give initial purchasers an option to buy up to an additional $60 million of notes. 

The company plans to use part of the proceeds to fund capped call transactions, which are intended to reduce potential dilution to common shareholders upon conversion. The remaining proceeds will be used for general corporate purposes, including the partial repayment of outstanding amounts under its Term Loan Credit Facility, along with accrued interest, fees and expenses. 

The notes will be offered to qualified institutional buyers under Rule 144A and will be senior unsecured obligations of Delek. 

Darden Restaurants Shares Fall 1.97% As Q1 Revenue Misses Expectations 

Darden Restaurants Inc. (NYSE: DRI) shares declined on September 24 after the restaurant operator reported first-quarter fiscal 2027 revenue slightly below analyst expectations, while adjusted earnings matched estimates. The stock opened at $208.88, reached an intraday high of $212.99, and fell to a low of $206.22. 

As of 2:14 p.m. ET, Darden Restaurants shares were trading at $209.48, down 1.97%, or $4.21, from the previous close of $213.69. The US market remains open, so the final closing price may change. 

Darden reported adjusted EPS of $2.05, in line with the $2.05 analyst consensus. Revenue rose 5.1% year-on-year to $3.2 billion, but came in below the $3.21 billion estimate. 

Blended same-restaurant sales increased 3.1% on a fiscal calendar basis, with LongHorn Steakhouse leading growth at 6.2%. Olive Garden, Darden’s largest brand, recorded same-restaurant sales growth of 1.1%. 

For fiscal 2027, the company reaffirmed its adjusted EPS outlook of $11.10–$11.35, with the midpoint of $11.23 slightly below the $11.28 analyst consensus. Darden also repurchased $222.3 million of its shares during the quarter and declared a quarterly dividend of $1.62 per share. 

Also Read: How to invest in US stocks

Redwire Shares Rise 3.82% After Winning Spot On $980 Million Space Testing Contract 

Redwire Corporation (NYSE: RDW) shares gained on September 24 after the space and defence technology company was selected as one of 15 vendors for a multiple-award contract with the US Space Systems Command valued at more than $980 million. The stock opened at $11.17, reached an intraday high of $11.86, and fell to a low of $11.01. As of 2:23 p.m. ET, Redwire shares were trading at $11.70, up 3.82%, or $0.43, from the previous close of $11.27. The US market remains open, so the final closing price may change. 

The contract, known as NITE-STAR, will support US national security testing infrastructure and operational readiness. Redwire will be eligible to provide design, development, integration, testing and sustainment services for space-based and ground-based systems. 

The company said the award does not guarantee revenue, as NITE-STAR is a multiple-award contract vehicle. The selection nevertheless expands Redwire’s access to potential work supporting the US Space Force and its national security portfolio. Redwire has approximately 1,400 employees across North America and Europe and provides spacecraft systems, digital engineering and space infrastructure solutions. 

BlackBerry Shares Rise 1.13% As Q2 Revenue Growth and QNX Design Wins Boost Outlook 

BlackBerry Ltd. (NYSE: BB) shares rose on September 24 as investors assessed the company’s second-quarter fiscal 2027 earnings update, which highlighted continued growth in its QNX automotive software business and higher full-year guidance. The stock opened at $8.42, reached an intraday high of $8.80, and fell to a low of $7.93. 

As of 2:35 p.m. ET, BlackBerry shares were trading at $8.48, up 1.13%, or $0.095, from the previous close of $8.385. The US market remains open, so the final closing price may change. 

BlackBerry reported 26% year-on-year revenue growth, marking its second consecutive Rule of 40 quarter. QNX generated record quarterly revenue of $80 million, supported by demand for software-defined vehicles and centralised computing architectures. 

The company also secured the largest design win in QNX’s history with Cortica, which management estimates could generate more than $100 million in future royalties. Design-win activity in the first half of the fiscal year has already exceeded the previous full-year record. 

BlackBerry raised its full-year revenue and adjusted EBITDA guidance for the second consecutive quarter and expects approximately $115 million in full-year operating cash flow. The company ended the period with a net cash position of $247 million. 

RAVE Restaurant Group Shares Fall 14.91% Despite Higher Fiscal 2026 Revenue 

RAVE Restaurant Group Inc. (NASDAQ: RAVE) shares fell sharply on September 24 after the restaurant operator reported its fourth-quarter and fiscal 2026 financial results. The stock opened at $2.29, reached an intraday high of $2.38, and fell to a low of $2.06. 

As of 2:33 p.m. ET, RAVE shares were trading at $2.34, down 14.91%, or $0.41, from the previous close of $2.75. The US market remains open, so the final closing price may change. 

For the fourth quarter, RAVE reported revenue of $3.4 million, up 8.8% year-on-year, while adjusted EBITDA increased 4.9% to $1.2 million. Net income, however, declined 6.2% to $0.8 million, with diluted EPS unchanged at $0.06. 

Full-year results were stronger, with revenue rising to $12.9 million from $12 million in fiscal 2025. Net income increased to $2.9 million, while adjusted EBITDA reached $3.9 million. Cash and short-term investments rose $3.7 million to $13.6 million. 

However, comparable-store sales remained uneven. Pizza Inn domestic comparable sales declined 2.8% in Q4, while Pie Five fell 17.3%. For fiscal 2026, Pizza Inn comparable sales increased 2.4%, while Pie Five declined 9.9%. RAVE said Pizza Inn has signed a 10-buffet development agreement, with the first five restaurants expected to open in fiscal 2027. 

Elmet Group Shares Fall 3.64% After $125 Million Masan High-Tech Materials Investment 

The Elmet Group Co. (NASDAQ: ELMT) shares fell on September 24 after the company announced a strategic investment of approximately $125 million in Vietnam-based Masan High-Tech Materials Corporation. The stock opened at $20.35, reached an intraday high of $20.41 and touched a low of $19.14. 

As of 2:55 p.m. ET, ELMT shares were trading at $19.83, down 3.64%, or $0.75, from the previous close of $20.58. The US market remains open, so the final closing price may change. 

Under the agreement, Elmet Group will acquire a 4.99% stake in Masan High-Tech Materials for $124.75 million. The investment will be accompanied by long-term agreements covering mined tungsten supplies from the Nui Phao Mine and tungsten conversion services from Masan’s refining complex in Vietnam. 

The companies said the relationship is intended to strengthen the tungsten supply chain, support higher refining throughput, enable new product development and expand international customer reach. Elmet will also receive one seat on Masan High-Tech Materials’ board. 

The transaction follows the US Government’s $450 million committed investment in Elmet announced on September 14, 2026, supporting the company’s strategy to build capabilities across the tungsten supply chain. 

Also Read: US Stock Market Timings 

Eli Lilly Shares Rise 3.24% After $3.35 Billion InnoCare Drug Discovery Pact 

Eli Lilly and Co. (NYSE: LLY) shares rose on September 24 after the pharmaceutical company entered a five-drug research and licensing partnership with China-based InnoCare Pharma. The stock opened at $1,156.67, reached an intraday high of $1,197.79 and touched a low of $1,151.00. 

As of 3:06 p.m. ET, LLY shares were trading at $1,188.32, up 3.24%, or $37.33, from the previous close of $1,150.99. The US market remains open, so the final closing price may change.  

Under the agreement, Lilly will pay up to $100 million upfront, with InnoCare eligible for a further $3.25 billion in development and commercial milestone payments, alongside royalties on sales of medicines arising from the collaboration. 

The companies said InnoCare will use its drug discovery platform to discover and advance compounds against up to five targets addressing unmet medical needs. Specific targets and drug candidates were not disclosed. 

InnoCare focuses on oncology and autoimmune diseases and has more than 10 innovative candidates in clinical development. The company has three approved medicines in China, including Yinuoxin, Hibruka and Minjuvi. 

The deal adds to Lilly’s expanding China strategy, following its collaboration with Innovent Biologics worth up to $8.5 billion announced in February 2026. Licensing activity between US and Chinese biopharma companies has also increased significantly in recent years. 

GoDaddy Shares Rise 4.85% After Reported Gen Digital Takeover Approach 

GoDaddy Inc. (NYSE: GDDY) shares rose on September 24 after a report that Gen Digital Inc. (NASDAQ: GEN), the owner of Norton and Avast, had approached the web-services company about a potential takeover. The stock opened at $97.22, reached an intraday high of $110.35 and touched a low of $94.70. 

As of 3:08 p.m. ET, GDDY shares were trading at $101.05, up 4.85%, or $4.67, from the previous close of $96.38. The US market remains open, so the final closing price may change. 

According to the Financial Times, Gen Digital made its initial approach in recent weeks, although discussions remain at an early stage. The report did not disclose financial terms, and there is no guarantee that the talks will result in a transaction. 

A potential combination would bring together GoDaddy’s domain registration, website hosting, website-building and payments services with Gen Digital’s consumer cybersecurity and identity-protection portfolio, which includes Norton, Avast and LifeLock. 

Gen Digital shares were reportedly down nearly 8% as investors assessed the potential deal. Both stocks had also faced pressure earlier in the week, with GDDY falling more than 7% over the previous two sessions. GoDaddy shares remain down more than 15% year-to-date, while Gen Digital shares have declined more than 5% over the same period. 

Worthington Enterprises Shares Rise 0.50% After Strong Q1 Results 

Worthington Enterprises Inc. (NYSE: WOR) shares gained on September 24 after the company reported first-quarter fiscal 2027 results that exceeded analyst expectations. The stock opened at $59.37, reached an intraday high of $60.95 and touched a low of $58.42. 

As of 3:02 p.m. ET, WOR shares were trading at $59.53, up 0.50%, or $0.30, from the previous close of $59.23. The US market remains open, so the final closing price may change. 

Worthington reported adjusted earnings per share of $0.82, above the $0.75 consensus estimate, while revenue rose 13% year-on-year to $343.9 million, exceeding the $331.3 million estimate. Organic growth reached 7%, with acquisitions contributing another 6%. 

Adjusted EBITDA increased 10% to $74 million, while free cash flow nearly doubled to $54 million from $27.9 million a year earlier. Operating cash flow also rose $25.7 million to $66.7 million. 

Building Performance Solutions revenue increased 16% to $215.1 million, while Trade & Specialty Solutions revenue rose 8% to $128.8 million. The company also repurchased 335,000 shares for $18.2 million and declared a quarterly dividend of $0.20 per share. 

CEO Joe Hayek highlighted growing demand for engineered ASME tanks used in liquid cooling systems for data centres as a key opportunity ahead. 

Blockchain.com and NYSE Partner To Explore 24/7 Trading of Tokenized Securities 

Blockchain.com and NYSE Group have signed a memorandum of understanding to explore access to tokenized US exchange-listed equities and ETFs through the NYSE’s previously announced digital alternative trading system (ATS), subject to regulatory approvals. 

The collaboration aims to connect NYSE’s tokenized securities platform with Blockchain.com’s global customer base, potentially expanding access to blockchain-based versions of traditional securities. Tokenized stocks can support fractional ownership, around-the-clock trading and onchain settlement, according to the companies. 

The partnership also includes plans for two-way market data distribution. ICE Data Services, NYSE’s affiliated business, may provide Blockchain.com’s crypto market data and analytics to its subscribers, while Blockchain.com plans to incorporate certain NYSE and ICE data feeds into its app. 

Blockchain.com said the integration could provide real-time stock information to its more than 44 million confirmed accounts. The companies said the initiative is designed to combine traditional market infrastructure with digital-asset technology and broaden access to tokenized securities globally. 

Also Read: What Are Fractional Shares? 

IEH Shares Rise 3.61% After $3.6 Million Defibrillator Connector Orders 

IEH Corporation (OTCQX: IEHC) shares rose on September 24 after the company announced $3.6 million in new orders for its Hyperboloid connectors from a leading mobile defibrillator manufacturer. The stock opened at $27.95, reached an intraday high of $29.05 and touched a low of $27.95. 

As of 2:46 p.m. ET, IEHC shares were trading at $28.70, up 3.61%, or $1.00, from the previous close of $27.70. The US market remains open, so the final closing price may change. 

The orders expand IEH’s presence beyond its recent defence-related contracts, including work supporting the PATRIOT and APKWS missile programmes, into the medical device market. 

IEH said its Hyperboloid contact technology is designed to withstand shock and vibration while maintaining low electrical resistance and supporting a high number of mating cycles. These characteristics are particularly relevant to mobile defibrillators used in ambulances and public settings. 

The company identified medical applications as a strategic growth priority alongside its defence business. 

Tessenderlo Group Shares Fall 1.22% After Completing FMC Investment 

Tessenderlo Group NV (EBR: TESB) shares fell on September 24 after the Belgian industrial group completed its minority equity investment in FMC Corporation. The stock opened at €20.50, reached an intraday high of €20.75 and touched a low of €20.30. 

As of 5:35 p.m. GMT+2, TESB shares were trading at €20.30, down 1.22%, or €0.25, from the previous close of €20.55. 

Under the completed transaction, Tessenderlo purchased 30,319,166 FMC shares at $13.30 each for approximately $403 million. The investment gives Tessenderlo an approximately 20% stake in FMC’s outstanding common stock. 

As part of the deal, Tessenderlo has the right to nominate one independent director to FMC’s board and has nominated Luc Tack, its chief executive officer. The company has also agreed to customary standstill restrictions while it holds FMC shares and is subject to a three-year lock-up period. 

The transaction follows a definitive agreement signed on June 30, 2026. FMC and Tessenderlo said all required closing conditions and regulatory approvals had been satisfied. The investment establishes Tessenderlo as a significant shareholder in FMC while creating a formal board-level connection between the two companies. 

Amaero Postpones U.S. IPO Citing Adverse Market Conditions 

Amaero Inc. has postponed its planned US initial public offering, citing adverse market conditions, according to a regulatory filing. The company had previously submitted a Registration Statement on Form S-1 to the US Securities and Exchange Commission, but the filing has not yet been declared effective. 

Amaero International Ltd. (ASX: 3DA), the company’s Australian-listed parent, saw its shares fall sharply on September 24. The stock opened at A$0.0035, reached an intraday high of A$0.0035 and touched a low of A$0.0028. As of the latest available data, 3DA shares were down 36.36%, while Amaero (AMRO) shares were unchanged. 

Under SEC rules, securities covered by the registration statement cannot be sold, and offers to purchase cannot be accepted, until the filing becomes effective. 

Amaero operates in the additive manufacturing industry, producing spherical refractory and titanium alloy metal powders and large near-net-shape components using Powder Metallurgy Hot Isostatic Pressing technology. 

Headquartered in McDonald, Tennessee, the company currently has a listing on the Australian Securities Exchange. The postponement delays its proposed entry into US public markets amid challenging market conditions. 

Frazier Life Sciences Files $75M IPO; RUI Holdings Prices $300K IPO; ARC Group Announces Share-Warrant Trading 

Frazier Life Sciences Acquisition Corp II filed with the SEC to raise up to $75 million in an IPO, with the IPO price set at $10.00 per Class A ordinary share. The company plans to list on Nasdaq. The filing represents the company’s initial step toward a public listing and provides capital for pursuing acquisition opportunities in the life sciences sector. 

RUI Holdings (RUIH) priced its IPO at $1.00 per share, raising $300,000 on 300,000 shares. The small offering size reflects the company’s early-stage profile and represents an initial public listing for the company. 

ARC Group Securities Acquisition I announced the separate trading of its Class A ordinary shares, warrants, and rights commencing 24 September 2026. The separation allows investors to trade the components independently and provides greater flexibility in the market for the company’s securities. 

Overall, September 24 trading reflected mixed reactions to earnings, financing activity, strategic investments and corporate developments. Several companies posted stronger-than-expected results or secured new business opportunities, but their shares moved lower as investors weighed guidance, revenue performance and capital-raising plans. Meanwhile, IPO filings, convertible note offerings and strategic transactions highlighted continued corporate activity across technology, healthcare, defence, industrial and consumer sectors. 

Source 

• https://www.nasdaq.com/ 

• spglobal.com/spdji/en/indices/equity/sp-500/ 

• https://www.dowjones.com/ 

• https://www.spglobal.com/spdji/en/indices/equity/dow-jones-industrial-average/ 

• https://www.spglobal.com/spdji/en/indices/equity/sp-500/ 

• https://www.nasdaq.com/market-activity/index/comp 

• https://www.nasdaq.com/market-activity/quotes/nasdaq-ndx-index 

• https://www.spglobal.com/spdji/en/indices/equity/sp-100/ 

• https://www.lseg.com/en/ftse-russell/indices/russell-us 

• https://www.nyse.com/index 

• https://www.nyse.com/index 

• https://www.spglobal.com/spdji/en/indices/equity/dow-jones-transportation-average/ 

• https://www.spglobal.com/spdji/en/indices/equity/dow-jones-utility-average/ 

• https://www.spglobal.com/spdji/en/indices/equity/dow-jones-composite-average/ 

• https://www.nasdaq.com/market-activity/index/sox 

• https://www.cboe.com/tradable_products/vix/